Medical Copywriter vs. General Copywriter for Healthtech

A talented general copywriter can write a great headline, a persuasive email, a clean landing page. What they usually can't do — not because they aren't skilled, but because it isn't their training — is sense where a piece of health-related copy quietly crosses from persuasive into misleading, or from casual into clinically inaccurate.

That distinction matters more in healthtech than almost any other industry, because the cost of getting it wrong isn't just a weak conversion rate. It's a rejected ad account, a compliance complaint, or — in the worst case — a patient making a decision based on something that wasn't actually true.

Below, I cover where general copywriters most often go wrong, show before-and-after examples of risky and more defensible copy, explain what clinical review actually adds, and finish with a checklist you can use to decide which content needs a specialist — and which doesn't.

Where general copywriters can get health claims wrong

• Outcome claims that sound fine but aren't defensible. "Feel better fast" reads as harmless marketing language to a general copywriter. To a compliance reviewer, it's an outcome claim — and in the US, the FTC expects health claims to be backed by competent and reliable scientific evidence before they're published.
• Implied claims nobody meant to make. Regulators judge the overall impression an ad creates, not just its literal words. A before-and-after photo, a "doctor-approved" badge, or a name like "AnxietyFree" can make a health claim even when no sentence on the page does.
• Absolute words that overpromise. "Safe," "proven," "cure," "guaranteed," and "no side effects" are rarely true without qualification in medicine — and they're among the words most likely to get telehealth ads rejected.
• Symptom language that reads as a diagnosis. Second-person copy that describes a symptom directly ("Struggling with racing thoughts at night?") can trigger platform restrictions around implying a viewer's health condition — a nuance that isn't obvious unless you've seen it flagged before.
• Urgency tactics borrowed from e-commerce. "Only 3 spots left" works for a product launch. Applied to a mental health or medical service, the same urgency framing can read as manipulative rather than motivating, and patients tend to notice the difference.
• Testimonials and consent treated as an afterthought. A general copywriter may not flag that a patient testimonial needs documented consent, that a dramatic individual result implies it's typical, or that "individual results may vary" doesn't fix a misleading testimonial on its own.

"None of these are writing mistakes. They're judgment calls that depend on understanding the clinical and regulatory context behind the words."

Before and after: risky vs. more defensible copy

Here's what those judgment calls look like on real copy. Each "after" version keeps the persuasive intent but removes the part that would be hard to defend if a platform reviewer, regulator, or patient challenged it.

1. The outcome promise

The original promises a clinical result on a timeline the company can't control. The rewrite promises what the service actually delivers — access and a plan — which is both checkable and true.

2. The symptom hook

The original addresses the reader as someone with a condition and edges toward diagnosing them. The rewrite describes the service instead of the viewer, so the right person still recognizes themselves without the ad assuming anything about them.

3. The "proven" claim

"Clinically proven" needs evidence that matches the exact product, dose, and population being advertised — not a study of something similar. "Completely safe" is almost never accurate for a prescription treatment. The rewrite moves the reassurance to where it truly lives: clinical oversight and honest safety information.

4. The testimonial

A dramatic result implies it's typical, and a small-print disclaimer doesn't undo that impression. The rewrite highlights the experience of care rather than an exceptional outcome — and, either way, there should be written consent from Sarah on file before it's published.

5. The urgency line

"Before it's too late" plays on fear in a context where people are already anxious, and false scarcity is a deceptive practice in its own right. The rewrite still nudges the reader to act now, but by making the next step feel easy rather than threatening.

"More defensible" doesn't mean automatically compliant. Every claim still needs real evidence behind it, and the right wording depends on your service, your market, and the platforms you advertise on.

What clinical expertise adds to the review process

It isn't that a medical copywriter automatically writes better sentences. It's that they can tell, often instinctively, when a claim needs a softer edge, when a symptom-focused hook is going to read as invasive rather than empathetic, and when "persuasive" language has quietly become "misleading" language. That instinct comes from having actually sat with patients, not from a style guide.

In a review, that shows up in a few specific ways:

• Matching the claim to the evidence. Reading the study behind a claim and checking whether it actually supports it — the same population, the same treatment, a meaningful outcome — rather than just confirming that "a study exists."
• Spotting implied claims. Noticing when an image, product name, or before-and-after framing promises more than the words do.
• Knowing what's missing. Flagging where safety information, eligibility criteria, or "a clinician will decide if this is right for you" language needs to appear for the copy to be honest.
• Reading it as a patient would. Catching copy that feels fine to a marketer but frightening, shaming, or confusing to someone who is unwell.
• Respecting scope of practice. Making sure copy doesn't imply that coaches, care navigators, or an app are diagnosing or treating when only a licensed clinician can.
• Knowing when to escalate. A clinical reviewer isn't a substitute for legal or regulatory counsel — but they're usually the person best placed to recognize when a claim needs one.

When a general copywriter is sufficient

To be fair to general copywriters — plenty of healthtech content doesn't need a clinical background at all. A skilled general copywriter is usually a perfectly good fit for:

• Hiring pages, culture content, and employer branding
• Internal communications and investor updates that make no patient-facing health claims
• General brand storytelling — your founding story, mission, and values
• Non-clinical product marketing, like scheduling features, app usability, or billing and account help
• B2B content about operations, integrations, or workflow, as long as it doesn't promise clinical results

The distinction matters most where content touches outcomes, symptoms, treatments, patient testimonials, or anything a regulator or ad platform would consider a health claim. Many teams get the best of both: a general copywriter drafts, and a clinically trained reviewer checks the parts that carry health claims.

A checklist for deciding when specialist review is needed

Before a piece of content goes live, run through these questions. If you answer "yes" to any of them, it's worth having someone with clinical training review it:

• Does it promise or imply a health outcome, improvement, or timeline?
• Does it name, describe, or hint at a symptom, condition, or diagnosis?
• Does it mention a treatment, medication, test, or device — or compare it to another option?
• Does it use words like "proven," "safe," "effective," "cure," "guaranteed," or "doctor-recommended"?
• Does it cite research, statistics, or clinical data?
• Does it include patient testimonials, case studies, or before-and-after images?
• Will it run as a paid ad on a platform with healthcare advertising policies?
• Is it aimed at a sensitive audience, such as people with mental health conditions, chronic illness, or minors?
• Does it make claims about privacy, data security, or how patient information is used?

And the single question underneath all of them: if this claim were challenged by a platform reviewer or a regulator, could the person who wrote it explain exactly why it's accurate and defensible? If the honest answer is "probably not," that's the content that needs a clinical eye on it — not necessarily everything you publish.

Sources and further reading

These are the guidelines I refer to most often when reviewing health claims. They're a starting point, not legal advice — rules vary by country, platform, and product category.

• FTC: Health Products Compliance Guidance — how the FTC expects health claims to be substantiated, including implied claims.
• FTC: Endorsement Guides — What People Are Asking — rules for testimonials, reviews, and typical results.
• HHS: HIPAA Privacy Rule and Marketing — when patient information can and can't be used in marketing.
• Google Ads: Healthcare and medicines policy — what's restricted or prohibited in health advertising on Google.
• Meta: Advertising Standards — including the rules on personal attributes that affect symptom-focused ad copy.
• UK ASA: CAP Code — for brands advertising in the UK, see the section on medicines, medical devices, and health-related products.

If you're not sure which side of the checklist your content falls on, that's exactly what my brand audit is for. I'll review your landing pages, ads, and patient-facing content, flag the claims that would be hard to defend, and suggest wording that keeps them persuasive. For more on getting the page itself right, read my telehealth landing page copy best practices.